89 related articles for article (PubMed ID: 18452814)
1. Correlation between BMD and bone scintigraphy in patients with prostate cancer.
Perk H; Yildiz M; Kosar A; Cerci S; Soyupek F; Ozorak A; Dilmen C
Urol Oncol; 2008; 26(3):250-3. PubMed ID: 18452814
[TBL] [Abstract][Full Text] [Related]
2. [Bone mineral density change: comparison between prostate cancer patients with or without metastases and healthy men (a North African ethnic group)].
Janane A; Hajji F; Ismail T; Jawad C; Crepin-Elondo J; Ghadouane M; Ameur A; Abbar M; Albouzidi A
Actas Urol Esp; 2011; 35(7):414-9. PubMed ID: 21550141
[TBL] [Abstract][Full Text] [Related]
3. Lumbar bone mineral density in prostate cancer patients with bone metastases.
Chang CH; Tsai CS; Jim YF; Wu HC; Lin CC; Kao A
Endocr Res; 2003 May; 29(2):177-82. PubMed ID: 12856804
[TBL] [Abstract][Full Text] [Related]
4. Total and regional bone mass in metastatic cancer of the prostate.
Rico H; Chapado MS; Revilla M; Bethencourt F; Villa LF; Guil M
Eur Urol; 1996; 30(1):73-6. PubMed ID: 8854071
[TBL] [Abstract][Full Text] [Related]
5. [The early scintigraphic diagnosis of bone metastases in prostatic carcinoma].
Petrov T; Tsvetkov M; Mladenov D; Kumanov Kh
Khirurgiia (Sofiia); 1991; 44(5):28-9. PubMed ID: 1844461
[TBL] [Abstract][Full Text] [Related]
6. Value of bone scintigraphy for detection and ageing of vertebral fractures in patients with severe osteoporosis and correlation between bone scintigraphy and mineral bone density.
Kucukalic-Selimovic E; Begic A
Med Arh; 2004; 58(6):343-4. PubMed ID: 15648229
[TBL] [Abstract][Full Text] [Related]
7. Relationship between 99Tcm-MDP uptake and bone mineral density in patients with prostatic carcinoma.
Sundkvist GM; Nilsson M; Ahlgren L; Lilja B; Mattsson S; Birch-Iensen M; Abrahamsson PA
Nucl Med Commun; 1991 Jul; 12(7):629-36. PubMed ID: 1923154
[TBL] [Abstract][Full Text] [Related]
8. [Bone scintigraphy in prostatic cancer. Correlation with clinical and laboratory features and with survival].
Lobo G; Ladrón de Guevara D; Salgado G; Donoso G; Bagus F
Rev Med Chil; 1999 Feb; 127(2):181-8. PubMed ID: 10436698
[TBL] [Abstract][Full Text] [Related]
9. The relationship between the serum prostate specific antigen and whole body scintigraphy in prostate cancer patients after prostatectomy.
Begic A; Kucukalic-Selimovic E; Obralic N; Duric O; Lacevic N; Begovic-Hadzimuratovic S; Skopljak A; Dzubur-Aganovic M
Med Arh; 2006; 60(1):54-5. PubMed ID: 16425536
[TBL] [Abstract][Full Text] [Related]
10. Bone mineral density and bone scintigraphy in adult Saudi female patients with osteomalacia.
El-Desouki MI; Othman SM; Fouda MA
Saudi Med J; 2004 Mar; 25(3):355-8. PubMed ID: 15048176
[TBL] [Abstract][Full Text] [Related]
11. Relationship between skeletal uptake of 99mTc-HMDP and bone mineral density in elderly women.
Kigami Y; Yamamoto I; Ohnishi H; Takada M; Matsushita R; Hamanaka Y; Ota T; Morita R
Ann Nucl Med; 1998 Feb; 12(1):15-20. PubMed ID: 9559957
[TBL] [Abstract][Full Text] [Related]
12. Staging of prostatic carcinoma with radionuclide bone scintigraphy and lymphography.
Hayward SJ; McIvor J; Burdge AH; Jewkes RF; Williams G
Br J Radiol; 1987 Jan; 60(709):79-81. PubMed ID: 3814999
[TBL] [Abstract][Full Text] [Related]
13. Sensitivity in detecting osseous lesions depends on anatomic localization: planar bone scintigraphy versus 18F PET.
Schirrmeister H; Guhlmann A; Elsner K; Kotzerke J; Glatting G; Rentschler M; Neumaier B; Träger H; Nüssle K; Reske SN
J Nucl Med; 1999 Oct; 40(10):1623-9. PubMed ID: 10520701
[TBL] [Abstract][Full Text] [Related]
14. Abnormalities in bone mineral density distribution and bone scintigraphy in patients with childhood onset hypopituitarism.
Kosowicz J; El Ali Z; Ziemnicka K; Sowinski J
J Clin Densitom; 2007; 10(3):332-9. PubMed ID: 17470407
[TBL] [Abstract][Full Text] [Related]
15. The role of Tc-99m (V) DMSA scintigraphy in the diagnosis and follow-up of lung cancer lesions.
Ergün EL; Kara PO; Gedik GK; Kars A; Türker A; Caner B
Ann Nucl Med; 2007 Jul; 21(5):275-83. PubMed ID: 17634845
[TBL] [Abstract][Full Text] [Related]
16. Bone loss in men with prostate cancer treated with gonadotropin-releasing hormone agonists.
Stoch SA; Parker RA; Chen L; Bubley G; Ko YJ; Vincelette A; Greenspan SL
J Clin Endocrinol Metab; 2001 Jun; 86(6):2787-91. PubMed ID: 11397888
[TBL] [Abstract][Full Text] [Related]
17. Association between bone scintigraphy and serum levels of procollagen (I) and PSA in the detection of bone disease in prostate cancer patients.
Zissimopoulos A; Bantis A; Stellos K; Petrakis G; Matthaios D
J BUON; 2008; 13(1):69-74. PubMed ID: 18404790
[TBL] [Abstract][Full Text] [Related]
18. The flare phenomenon on radionuclide bone scan in metastatic prostate cancer.
Pollen JJ; Witztum KF; Ashburn WL
AJR Am J Roentgenol; 1984 Apr; 142(4):773-6. PubMed ID: 6230903
[TBL] [Abstract][Full Text] [Related]
19. Soft-tissue uptake of technetium-99m-MDP after prostate cryoablation.
Zucker I; Charkes ND; Seidmon EJ; Maurer AH
J Nucl Med; 1997 Apr; 38(4):525-8. PubMed ID: 9098195
[TBL] [Abstract][Full Text] [Related]
20. The utility of a deep learning-based algorithm for bone scintigraphy in patient with prostate cancer.
Aoki Y; Nakayama M; Nomura K; Tomita Y; Nakajima K; Yamashina M; Okizaki A
Ann Nucl Med; 2020 Dec; 34(12):926-931. PubMed ID: 32955663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
